University of North Carolina, Chapel Hill: Psychotic Disorders trials

The registry lists 24 Psychotic Disorders studies with University of North Carolina, Chapel Hill as lead sponsor. 1 are open to participants now and 13 have results posted.

Early Phase 1 1Phase 1 2Phase 2 1Phase 4 2No phase 18(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Examining the Effects of Estradiol on Neural and Molecular Response to RewardRecruitingNCT05282277Phase 4
• Enhancing Mental Health Outcomes for Patients With Psychosis in Malawi Through Community-based RehabilitationCompletedNCT06080477Not applicableResults posted
• Horyzons: Implementation and Integration in Clinical PracticeTerminatedNCT06002958Not applicableResults posted
• Horyzons: Implementation in Clinical PracticeCompletedNCT04673851Not applicableResults posted
• Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life Randomized Control TrialCompletedNCT04173572Not applicableResults posted
• Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance LifeCompletedNCT03757988Not applicableResults posted
• Targeting Auditory Hallucinations With Alternating Current StimulationCompletedNCT03221270Not applicableResults posted
• Targeting Stress Reactivity in Schizophrenia: Integrated Coping Awareness TherapyCompletedNCT03067311Not applicableResults posted
• MEtformin and Lorcaserin for WeighT Loss in SchizophreniaTerminatedNCT02796144Phase 4Results posted
• STimulation to Improve Auditory haLLucinationsCompletedNCT02360228Not applicableResults posted
• Transcranial Current Stimulation as a Treatment for Auditory Hallucinations in SchizophreniaCompletedNCT01963676Not applicableResults posted
• Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and AdolescentsCompletedNCT01731119Phase 2Results posted
• Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) StudyCompletedNCT01269710Results posted
• Oxytocin Treatment of SchizophreniaCompletedNCT01028677Not applicableResults posted
• Effects Zulresso on Postpartum PsychosisCompletedNCT05314153Early Phase 1
• Improving Access to Early Psychosis Coordinated Specialty CareCompletedNCT04277585Not applicable
• Behavioral Activation for Heroin Use in China: A Randomized Controlled TrialCompletedNCT03705143Not applicable
• Oxytocin Treatment of Social Cognitive and Functional Deficits in SchizophreniaCompletedNCT01394471Phase 1
• Intensive Computerized Brain Training (ICBT) in Youth With Early Onset Psychosis (EOP)CompletedNCT01027962Not applicable
• Effect of Antipsychotics on Appetite RegulationCompletedNCT00903916
• Overcoming Psychiatric Barriers to the Treatment of Hepatitis CCompletedNCT00407732Not applicable
• Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and QuetiapineCompletedNCT00312598
• Graduated Recovery Intervention Program for Enhancing Treatment for First-Episode PsychosisCompletedNCT00307216Not applicable
• Study of Amantadine for Weight Stabilization During Olanzapine TreatmentCompletedNCT00287352Phase 1